Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring
about
Advances in targeted proteomics and applications to biomedical researchBottom up proteomics data analysis strategies to explore protein modifications and genomic variants.Delineation of concentration ranges and longitudinal changes of human plasma protein variants.MALDI-target integrated platform for affinity-captured protein digestionMass spectrometric quantification of urinary human liver fatty acid binding protein in renal transplant recipients.Mass spectrometric immunoassays for discovery, screening and quantification of clinically relevant proteoforms.Mass Spectrometric Immunoassays in Characterization of Clinically Significant Proteoforms.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.MRM for the verification of cancer biomarker proteins: recent applications to human plasma and serum.Seminal plasma as a diagnostic fluid for male reproductive system disorders.Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.Quantification of biopharmaceuticals and biomarkers in complex biological matrices: a comparison of liquid chromatography coupled to tandem mass spectrometry and ligand binding assays.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Human proteoforms as new targets for clinical mass spectrometry protein tests.Mutant Proteogenomics.Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential.
P2860
Q28066912-773506BB-DF7C-4131-9BB4-E3DFA081CA97Q30893312-410D705A-1678-49DF-9B7B-A3984DBA5626Q33793513-414285A4-38D3-4106-9B0A-63BD321C704EQ35072160-B99D2076-28A6-4325-916D-0071E20F4E6CQ35979058-68BE9D1F-3DA3-439B-99EA-DF5ABB5D95AFQ36072250-CF2828CF-1C14-47F3-BB74-EFA37F0EC677Q37566426-2AC4F1EE-CE81-4AAB-8726-DC289CA7F620Q37651691-B8210EF0-3B3B-4AD6-8728-C00E056206C7Q38183147-D28A9D5C-A2D2-43BF-9D59-D4763F1F05D8Q38202841-C455A56F-4A84-4887-AFA7-0D800910F50AQ38203040-C4AB4DB9-1D90-4B12-88BA-2D2F8801FB5BQ38500988-31EFF051-755F-4813-953A-DBE2422C8641Q38604366-ABFBE8CC-9BB5-4EAB-A429-3E6F2111C6CDQ38649742-311F8B85-3AFC-45FB-92DF-422983CCBB07Q38816286-DB89D1C5-9A79-40C0-B748-7377739438D6Q39657160-10BC4CB6-C656-4CC0-A3EF-A0CF4BC9CC26
P2860
Identification of a novel proteoform of prostate specific antigen (SNP-L132I) in clinical samples by multiple reaction monitoring
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of a novel prot ...... y multiple reaction monitoring
@ast
Identification of a novel prot ...... y multiple reaction monitoring
@en
Identification of a novel proteoform of prostate specific antigen
@nl
type
label
Identification of a novel prot ...... y multiple reaction monitoring
@ast
Identification of a novel prot ...... y multiple reaction monitoring
@en
Identification of a novel proteoform of prostate specific antigen
@nl
prefLabel
Identification of a novel prot ...... y multiple reaction monitoring
@ast
Identification of a novel prot ...... y multiple reaction monitoring
@en
Identification of a novel proteoform of prostate specific antigen
@nl
P2093
P2860
P50
P356
P1476
Identification of a novel prot ...... y multiple reaction monitoring
@en
P2093
Akos Végvári
Karin Sjödin
Melinda Rezeli
P2860
P304
P356
10.1074/MCP.M113.028365
P577
2013-07-10T00:00:00Z